Research Output per year
Research Output per year
Fingerprint
Dive into the research topics where Medicine, Hematology Oncology Division is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Yasmin Abaza
- Medicine, Hematology Oncology Division - Assistant Professor
- Robert H. Lurie Comprehensive Cancer Center - Member
Person: Academic
-
Kehinde Adekola
- Medicine, Hematology Oncology Division - Associate Professor
- Robert H. Lurie Comprehensive Cancer Center - Member
Person: Academic
-
Jessica K Altman
- Medicine, Hematology Oncology Division - Professor
- PCE - Proteomics Center of Excellence - Member
- Robert H. Lurie Comprehensive Cancer Center - Member
Person: Academic
-
A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesis
Haque, T., Shastri, A., Desai, P., Xie, Z., Hammond, D., King, Z., Kishtagari, A., Madanat, Y. F., Abaza, Y., Silver, A. J., Singh, A., Borate, U. M., Heimlich, J. B., Slosky, D. A., Bolton, K. L., Patnaik, M. S., Bick, A. G., Verma, A. K., Jaiswal, S. & Steensma, D. P. & 1 others, , Feb 2025, In: British Journal of Haematology. 206, 2, p. 416-427 12 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
Abrupt fluoroquinolone-associated suicides: a SONAR report from North America, Europe, Australia, and Asia
for the Southern Network and Advserse Reactions, 2025, (Accepted/In press) In: European Journal of Internal Medicine.Research output: Contribution to journal › Letter › peer-review
-
Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial
Jillella, A. P., Lee, S. J., Altman, J. K., Luger, S. M., Tallman, M. S., Foran, J. M., Bradshaw, D., Law, L. Y., Bryan, L. J., Abou Zahr, A., Begna, K. H., Perl, A. E., Vadakara, J. J. L., Qamar, R., Bergan, R. C., Fisch, M. J., Carlos, R. C., Wagner, L. I., Kota, V. K. & Litzow, M. R., 2025, (Accepted/In press) In: JAMA Oncology.Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Datasets
-
Detection of monkeypox virus using helicase dependent amplification and recombinase polymerase amplification combined with lateral flow test
Wu, G. (Creator), GuliNaizhaer, A. (Contributor), Fan, X. (Creator), Ma, S. (Creator), Yang, C. (Creator) & Zou, M. (Creator), figshare, 2024
DOI: 10.6084/m9.figshare.c.6946443.v1, https://springernature.figshare.com/collections/Detection_of_monkeypox_virus_using_helicase_dependent_amplification_and_recombinase_polymerase_amplification_combined_with_lateral_flow_test/6946443/1
Dataset
-
Quercetin enhances the anti-tumor effects of BET inhibitors Supplementary Figures
Pham, T. (Contributor), ZENODO, Jul 10 2019
DOI: 10.5281/zenodo.3284893, https://zenodo.org/record/3284893
Dataset
-
The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells
Salem, I. (Contributor), Alsalahi, M. (Creator), Chervoneva, I. (Creator), Aburto, L. D. (Creator), Addya, S. (Creator), Ott, G. R. (Creator), Ruggeri, B. A. (Creator), Cristofanilli, M. (Creator) & Fernandez, S. V. (Creator), figshare, 2016
DOI: 10.6084/m9.figshare.c.3612563, https://figshare.com/collections/The_effects_of_CEP-37440_an_inhibitor_of_focal_adhesion_kinase_in_vitro_and_in_vivo_on_inflammatory_breast_cancer_cells/3612563
Dataset
-
Prot #NU 24N04: A Phase 2 Open Label Study of XL092 as First Line Therapy in Radioiodine Refractory Differentiated Thyroid Cancer
Lorch, J.H.-M. (PD/PI)
5/30/25 → 5/30/28
Project: Research project
-
Prot #BH-30236-01: A Phase 1/1b Open-Label, Dose Escalation, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-leukemic Activity of the Orally Available CDC-Like Kinase (CLK) Inhibitor, BH-30236, in Adults
Altman, J. K. (PD/PI)
Pharmaceutical Research Associates, Inc., BlossomHill Therapeutics, Inc.
5/28/25 → 5/28/28
Project: Research project
-
Prot #NKT2152-101: A Phase 1/2, Open Label Dose-Escalation and Expansion Trial of NKT2152, an Orally Administered HIF-2α Inhibitor, to Investigate Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity in Patients with Advanced Clear Cell Renal
VanderWeele, D. J. (PD/PI)
Medpace Clinical Research LLC, NiKang Therapeutics, Inc.
5/23/25 → 5/23/28
Project: Research project